Literature DB >> 10916097

Renal nitric oxide production during the early phase of experimental diabetes mellitus.

S Keynan1, B Hirshberg, N Levin-Iaina, I D Wexler, R Dahan, E Reinhartz, H Ovadia, Y Wollman, T Chernihovskey, A Iaina, I Raz.   

Abstract

BACKGROUND: Diabetic nephropathy (DN) is characterized by hyperfiltration and hypertrophy in experimental models of diabetes mellitus (DM). Several studies have demonstrated that the pathophysiologic and morphologic changes in DN are mediated by either an increase or decrease in renal nitric oxide (NO) production and/or activity. The goal of the present study was to determine the effects that the early diabetic state has on NO production in the kidney of rats with streptozotocin-induced DM.
METHODS: Experimental DM was induced in rats with streptozotocin. Urinary NO production was measured, and levels and activity of the different NOS isoforms were determined by a combination of techniques, including immunoblotting, immunohistochemistry, diaphorase staining, and reverse transcription-polymerase chain reaction.
RESULTS: During the first week of DM, urinary NO metabolites (uNO2 + NO3) were reduced as compared with controls, which were unrelated to changes in serum levels of NO. Total NO synthase (NOS) activity was reduced in the renal cortex beginning at 30 hours after the induction of DM. NADPH diaphorase staining of renal cortical slices showed reduced NOS activity in the macula densa in diabetic animals. By immunohistochemical staining with antibodies to the different isoforms of NOS, it was found that protein levels of the neuroneal NOS (nNOS) isoform was diminished in the macula densa. No changes were found in the levels of endothelial NOS (eNOS) activity and protein in the renal cortex in the early diabetic state.
CONCLUSIONS: This study provides strong evidence that renal production of NO is reduced in early DM and that this reduction is associated with decreased levels of nNOS activity and protein in the macula densa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10916097     DOI: 10.1046/j.1523-1755.2000.00220.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.

Authors:  Hanning You; Ting Gao; Timothy K Cooper; Sidney M Morris; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

2.  Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue.

Authors:  C Hu; X D Cong; De-Zai Dai; Y Zhang; G L Zhang; Y Dai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-26       Impact factor: 3.000

Review 3.  Pathogenic role of nitric oxide alterations in diabetic nephropathy.

Authors:  Sharma S Prabhakar
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

4.  Over-production of nitric oxide by oxidative stress-induced activation of the TGF-β1/PI3K/Akt pathway in mesangial cells cultured in high glucose.

Authors:  Yun-peng Zhai; Qian Lu; Yao-wu Liu; Qian Cheng; Ya-qin Wei; Fan Zhang; Cheng-lin Li; Xiao-xing Yin
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

5.  Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes.

Authors:  Cathy Grutzmacher; SunYoung Park; Yun Zhao; Margaret E Morrison; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-17

6.  Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.

Authors:  Shinsuke Miyahara; Junichi Kiryu; Kenji Yamashiro; Kazuaki Miyamoto; Fumitaka Hirose; Hiroshi Tamura; Hideto Katsuta; Kazuaki Nishijima; Akitaka Tsujikawa; Yoshihito Honda
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy.

Authors:  Shinichi Okada; Motoaki Saito; Emi Kazuyama; Takuya Hanada; Yasuo Kawaba; Atsushi Hayashi; Keisuke Satoh; Susumu Kanzaki
Journal:  Mol Cell Biochem       Date:  2008-06-05       Impact factor: 3.396

Review 8.  Renal endothelial dysfunction in diabetic nephropathy.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014

Review 9.  Role of glomerular filtration rate in controlling blood pressure early in diabetes.

Authors:  Michael W Brands; Hicham Labazi
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

Review 10.  Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes.

Authors:  Sevda Gheibi; Alan P Samsonov; Shahsanam Gheibi; Alexandra B Vazquez; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.